Just a reminder, as the info from the Miami New Times report sinks in, what Alex Rodriguez had to say at his 2009 press conference after he was revealed to have tested positive for PEDs during baseball’s pilot testing program:
“Going back to 2001, my cousin started telling me about a substance that you could purchased over the counter in the DR [Dominican Republic]. In the streets, it’s known as ‘boli’ or ‘bole.’ It was his understanding that it would give me a dramatic energy boost and [was] otherwise harmless. My cousin and I, one more ignorant than the other, decided it was a good idea to start taking it … I stopped taking it in ’03 and haven’t taken it since.”
The entire transcript of that press conference can be read here.
When we talk about Roger Clemens and Barry Bonds, we’re talking about players who allegedly (but far from conclusively) lied about their PED use which, based on the best evidence available, took place prior to MLBs institution of testing and enforcement for banned substances.
With A-Rod, we have a player who, unless the records in this new report were fabricated, clearly lied about his drug use and continued to take banned drugs long after MLB’s testing and real enforcement of its drug policies began. To the extent judgments are to be passed on these respective players’ acts now and in the future, I think this distinction is pretty significant.
The Yankees appear to have moved on from free agent Manny Machado this winter, but could they be turning their attention to Rockies superstar Nolan Arenado? That’s the idea floated by Andy Martino of SNY, who hears that GM Brian Cashman has been involved in recent discussions concerning the third baseman. No official comments have been made to the press yet, though, and it’s not clear whether the Yankees would prefer to pursue Arenado prior to the 2019 season or partway through it.
The 27-year-old infielder earned his fourth consecutive All-Star nomination, Silver Slugger, and Gold Glove award in 2018 after slashing .297/.374/.561 with 38 home runs, a .935 OPS, and 5.7 fWAR across 673 plate appearances. There’s no question he’s provided immense value to Colorado’s lineup over the last half-decade, and his consistency and incredible power at the plate helped form the basis of the record $30 million arbitration figure he presented to the team last week. The Rockies countered at $24 million, however, and in doing so may have jeopardized their chances of convincing the infielder to forego free agency in 2020 and take a long-term deal instead.
Assuming he declines to negotiate an extension with the Rockies, Arenado’s decorated résumé and career-best 2018 numbers should attract plenty of interest around the league — a reality that could put considerable pressure on the Yankees (or any other interested party) to finesse a deal sooner rather than later. For now, the club is prepared to enter the 2019 season with hot-hitting third baseman Miguel Andújar, whom Martino speculates would be the “centerpiece” of any trade with Colorado.